AVS Pulse - About the company
AVS Pulse is an acquired company based in Ann Arbor (United States), founded in 2017 by Robert Chisena. It operates as a Developer of a medical device to treat severely calcified arterial disease. AVS Pulse has raised $70.4M in funding from BioStar Capital. The company has 63 active competitors, including 17 funded and 15 that have exited. Its top competitors include companies like Silk Road Medical, Lifetech Scientific Corporation and Supira Medical.
Company Details
Developer of a medical device to treat severely calcified arterial disease. The company develops pulsatile intravascular lithotripsy (PIVL), a therapy device that is delivered through a balloon-based platform called PULSE IVL System to restore blood flow to blockages in the legs caused by severe calcium buildup.
- Website
- avspulse.com
- Email ID
- *****@avspulse.com
- Phone Number
- +1 **********
Key Metrics
Founded Year
2017
Location
Ann Arbor, United States
Stage
Acquired
Total Funding
$70.4M in 5 rounds
Latest Funding Round
Investors
Ranked
5th among 63 active competitors
Employee Count
36 as on Mar 31, 2026
Similar Companies
Exit Details
Acquired by Stryker (Apr 13, 2026)
AVS Pulse's acquisition details
AVS Pulse got acquired by Stryker on Apr 13, 2026.
Click here to take a look at AVS Pulse's acquisition in detail
Sign up to download AVS Pulse's company profile
AVS Pulse's funding and investors
AVS Pulse has raised a total funding of $70.4M over 5 rounds. Its first funding round was on Jul 07, 2020. Its latest funding round was a Series B round on Oct 15, 2024 for $*****. 2 investors participated in its latest round. AVS Pulse has 3 institutional investors.
Here is the list of recent funding rounds of AVS Pulse:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Oct 15, 2024 | 2570411 | Series B | 2388903 | 2871796 | 3491517 | 3826067 |
Apr 04, 2023 | 6623877 | Series B | 1261981 | 1965943 | 9915201 | |
Jan 05, 2023 | 1381685 | Series B | 2426432 | 1864866 | 2976994 |
View details of AVS Pulse's funding rounds and investors
AVS Pulse's founders and board of directors
Founder? Claim ProfileThe founders of AVS Pulse is Robert Chisena. Mark Toland is the CEO of AVS Pulse.
Here are the details of AVS Pulse's key team members:
- Robert Chisena: Co-Founder & CTO of AVS Pulse. Contact Info: 1 email address
- Mark Toland: CEO of AVS Pulse. Contact Info: 1 email address
View details of AVS Pulse's Founder profiles and Board Members
AVS Pulse's employee count trend
AVS Pulse has 36 employees as of Mar 26. Here is AVS Pulse's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
AVS Pulse's Competitors and alternates
Top competitors of AVS Pulse include Silk Road Medical, Lifetech Scientific Corporation and Supira Medical. Here is the list of Top 10 competitors of AVS Pulse, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Silk Road Medical 2007, Sunnyvale (United States), Acquired | Provider of neuroprotection devices for carotid artery disease | $189M | 63/100 | |
2nd | Lifetech Scientific Corporation 1999, Shenzhen (China), Public | Interventional medical devices to treat cardiovascular and peripheral vascular diseases. | $66.2M | 59/100 | |
3rd | Supira Medical 2016, Campbell (United States), Series E | Developer of ventricular assist devices for coronary intervention and cardiogenic shock | $240M | 59/100 | |
4th | AMT Medical 2016, Utrecht (Netherlands), Series B | Providing solutions for heart bypass surgery | $36.7M | 55/100 | |
5th | AVS Pulse 2017, Ann Arbor (United States), Acquired | Developer of a medical device to treat severely calcified arterial disease | $70.4M | 59/100 | |
6th | Coronary stenting system | - | 48/100 | ||
7th | SIS Medical 2006, Winterthur (Switzerland), Late Stage | Distributor of medical and surgical supplies | - | 46/100 | |
8th | CardiacBooster 2018, Nijmegen (Netherlands), Funding Raised | Provider of percutaneous left ventricular assist devices | - | 45/100 | |
9th | Protaryx Medical 2019, Baltimore (United States), Series A | Developer of smart medical devices for the treatment of atrial septum of the heart diseases | $8.3M | 40/100 | |
10th | Shanghai Baixin'an Biotechnology 2014, Pudong (China), Public | Developer of coronary stent system | $15.8M | 40/100 |
Looking for more details on AVS Pulse's competitors? Click here to see the top ones
AVS Pulse's Investments and acquisitions
AVS Pulse has made no investments or acquisitions yet.
News related to AVS Pulse
Media has covered AVS Pulse for a total of 4 events in the last 1 year, 2 of them have been about company updates.
•
•
•
Avs Completes A $36m Series B Financing Ahead Of Ivl U.s. Commercial Launchintelligence360•Feb 05, 2025•AVS Pulse
•
AVS Completes a $36M Series B Financing Ahead of IVL U.S. Commercial LaunchBusiness Wire•Jan 28, 2025•AVS Pulse, BioStar Capital, Cue Growth Partners
•
•
AVS and Jacobs Institute Collaborate on Coronary and Carotid Clinical TrialsMedical Product Outsourcing•Sep 12, 2024•AVS Pulse, Jacobsinstitute
•
•
AVS Receives IDE Approval from FDA for Pivotal Intravascular Lithotripsy StudyBusiness Wire•Jun 06, 2024•AVS Pulse
•
•
AVS Collects an Additional $8.8 Million in its Series B Funding RoundMedical Product Outsourcing•May 30, 2023•AVS Pulse, BioStar Capital, Cue Growth Partners
Are you a Founder ?
FAQs about AVS Pulse
Explore our recently published companies
- Exigent Info - Unfunded company
- Virbhumi - Mumbai based, Funding Raised company
- UNRL - 2017 founded, Public company
- Ragtos - Unfunded company
- FW Murphy Production Controls - San Antonio based, 1939 founded, Acquired company
- Evergreenmgt - United States based, 1999 founded, Unfunded company
